“bayer” Archives

in
Entry Author Date Location
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More 10/02/20 National
Monte Rosa Raises $96M for “Glue-Based” Protein Degrading Drugs 09/24/20 Boston
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Bio Roundup: J&J Buyout, BioMarin Rebuffed, Poseida on Hold & More 08/21/20 National
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
Bayer Boosts Women’s Health Drug Pipeline, Paying $425M for KaNDy 08/11/20 Europe
Dewpoint, Merck Team Up to Tackle HIV Using Condensate Know-How 07/15/20 Boston
AsclepiX Emerges With $35M and an Eye Drug Challenger to Eylea, Lucentis 06/24/20 National
After Inking Bristol Myers Pact, Repare Therapeutics Sets Sights on IPO 05/29/20 Boston
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
Kymera Closes $102M Round to Bring Protein-Busting Drugs to the Clinic 03/12/20 Boston
Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution’s IPO & More 02/14/20 National
CEOs of Women’s Health Companies Fight to Open Investment Floodgates 01/22/20 San Diego
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
Daré Bioscience Inks Deal With Bayer for Non-Hormonal Contraceptive 01/14/20 San Diego
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More 11/15/19 National
Daré to Add Microchip-Based Birth Control to Women’s Health Portfolio 11/15/19 San Diego
Bayer and Dewpoint Ink Deal for Drugs R&D at New Frontier of Biology 11/14/19 Boston
Bio Roundup: Biogen’s Reversal, FDA Moves Fast, a CF Cocktail & More 10/25/19 National
Plexium Debuts With $28M and a New Take on Protein Degradation Drugs 10/17/19 San Diego
High-Flying Ginkgo Nets Another $290M to Program Cells Like Computers 09/19/19 Boston
Elanco’s $7.6B Deal With Bayer Bolsters Pets, Farm Animals Footprint 08/20/19 Indiana
Four New Drugs Are Around the Corner. Here’s What You Need to Know. 08/15/19 National
Bio Roundup: Surprise News, a Gene Therapy Mess & a CAR-T Step 08/09/19 National
Bayer Buys Out BlueRock, Betting at Least $240M More on Cell Therapy Work 08/08/19 Boston
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More 08/02/19 National
Joyn Bio Reaches Deal to Tap Into NewLeaf’s Plant Microbe Library 07/22/19 Boston
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D 06/12/19 Boston
Bayer and Arvinas Join Forces in $115M Pharma & Ag Research Alliance 06/04/19 Boston
Ginkgo Eyes Antibiotics With Deal for Warp Drive’s Gene “Mining” Tech 05/15/19 Boston
Page 1 of 8 next page »